Methyl N-{(4S,5S)-5-[(L-alanyl-L-alanyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate

L-Valine, N-[(4S,5S)-5-[[(2S)-2-[[(2S)-2-amino-1-oxopropyl]amino]-1-oxopropyl]amino]-4-hydroxy-1-oxo-6-phenylhexyl]-L-valyl-, methyl ester

Methyl N-{(4S,5S)-5-[(L-alanyl-L-alanyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinate

Methyl-N-{(4S,5S)-5-[(L-alanyl-L-alanyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-valyl-L-valinat

N-{(4S,5S)-5-[(L-Alanyl-L-alanyl)amino]-4-hydroxy-6-phénylhexanoyl}-L-valyl-L-valinate de méthyle

126333-28-6

144285-77-8

2-(2-{5-[2-(2-AMINO-PROPIONYLAMINO)-PROPIONYLAMINO]-4-HYDROXY-6-PHENYL-HEXANOYLAMINO}-3-METHYL-BUTYRYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER

5-(L-Alanyl-L-alanylamino)-4-hydroxy-6-phenylhexanoic acid, methyl valyl-valyl amide

ALA-ALA-PHE-ψ((S)-CHOH-CH2)-GLY-VAL-VAL-OME

C-terminal inhibitor 1

Dimer of Gag-Pol polyprotein [489-587]

Gag-Pol polyprotein

GLI

Hydroxyethylene isostere analog(AA-II-VV-OMe)

L-Valine, L-alanyl-L-alanyl-(gammaS, deltaS)-delta-amino-gamma-hydroxybenzenehexanoyl-L-valyl-, methyl ester

L-Valine, L-alanyl-L-alanyl-(γS, δS)-δ-amino-γ-hydroxybenzenehexanoyl-L-valyl-, methyl ester

METHYL (2S)-2-[(2S)-2-[(4S,5S)-5-[(2S)-2-[(2S)-2-AMINOPROPANAMIDO]PROPANAMIDO]-4-HYDROXY-6-PHENYLHEXANAMIDO]-3-METHYLBUTANAMIDO]-3-METHYLBUTANOATE

methyl (2S)-2-[[(2S)-2-[[(4S,5S)-5-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-4-hydroxy-6-phenylhexanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoate

POL_HV1N5

PSI